A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis

Gauruv Bose(University of Ottawa), Mark S. Freedman(University of Ottawa), Harold Atkins(University of Ottawa), Carolina Rush(University of Ottawa)
Multiple Sclerosis and Related Disorders
April 14, 2021
Cited by 30


Related Papers